Table 6.
Five-Year Total, Annual Average Totala, and Average Annual Age-Adjusted Incidence Ratesb with 95% Confidence Intervals for Selected Non-Malignant Histologies by Sex, Age Group at Diagnosis, Race, and Hispanic Ethnicity and Histology, CBTRUS Statistical Report: U.S. Cancer Statistics – NPCR and SEER, 2014–2018
| Group | Vestibular Schwannomac | Pituitary Adenomad | WHO Grade I Meningiomae | WHO Grade II Meningiomaf | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-Year Total | Annual Average | 95% CI | 5-Year Total | Annual Average | 95% CI | 5-Year Total | Annual Average | 95% CI | 5-Year Total | Annual Average | 95% CI | |
| Sex | ||||||||||||
| Male | 12,874 | 2,575 | 1.49 (1.46–1.51) | 28,821 | 5,764 | 3.41 (3.37–3.45) | 13,080 | 2,616 | 1.52 (1.49–1.55) | 3,913 | 783 | 0.46 (0.44–0.47) |
| Female | 14,478 | 2,896 | 1.54 (1.51–1.57) | 35,408 | 7,082 | 4.21 (4.17–4.26) | 35,173 | 7,035 | 3.71 (3.67–3.75) | 5,358 | 1,072 | 0.57 (0.56–0.59) |
| Age Groups | ||||||||||||
| 0–14 years | 197 | 39 | 0.06 (0.06–0.07) | 926 | 185 | 0.30 (0.28–0.32) | 99 | 20 | 0.03 (0.03–0.04) | 69 | 14 | 0.02 (0.02–0.03) |
| 15–39 years | 3,655 | 731 | 0.70 (0.68–0.73) | 18,452 | 3,690 | 3.45 (3.40–3.50) | 4,115 | 823 | 0.82 (0.80–0.85) | 1,044 | 209 | 0.20 (0.19–0.21) |
| 40–64 years | 14,440 | 2,888 | 2.59 (2.54–2.63) | 27,344 | 5,469 | 5.19 (5.12–5.25) | 24,426 | 4,885 | 4.40 (4.34–4.46) | 4,443 | 889 | 0.80 (0.78–0.82) |
| 65+ years | 9,060 | 1,812 | 3.65 (3.57–3.72) | 17,507 | 3,501 | 7.18 (7.07–7.29) | 19,613 | 3,923 | 8.05 (7.94–8.16) | 3,715 | 743 | 1.54 (1.49–1.59) |
| Race | ||||||||||||
| White | 23,537 | 4,707 | 1.61 (1.58–1.63) | 45,899 | 9,180 | 3.40 (3.37–3.43) | 38,684 | 7,737 | 2.60 (2.58–2.63) | 7,077 | 1,415 | 0.48 (0.47–0.49) |
| Black | 1,496 | 299 | 0.69 (0.65–0.73) | 12,835 | 2,567 | 6.04 (5.94–6.15) | 6,223 | 1,245 | 2.96 (2.88–3.03) | 1,452 | 290 | 0.69 (0.65–0.72) |
| American Indian/Alaska Native | 159 | 32 | 0.77 (0.65–0.90) | 541 | 108 | 2.61 (2.38–2.84) | 313 | 63 | 1.65 (1.47–1.86) | 52 | 10 | 0.28 (0.21–0.38) |
| Asian or Pacific Islander | 1,525 | 305 | 1.46 (1.39–1.54) | 3,583 | 717 | 3.45 (3.33–3.56) | 2,402 | 480 | 2.36 (2.26–2.46) | 548 | 110 | 0.54 (0.49–0.58) |
| Hispanic Ethnicity | ||||||||||||
| Non-Hispanic | 25,058 | 5,012 | 1.59 (1.57–1.62) | 53,707 | 10,741 | 3.70 (3.67–3.73) | 43,175 | 8,635 | 2.70 (2.68–2.73) | 8,396 | 1,679 | 0.53 (0.52–0.54) |
| Hispanic | 2,294 | 459 | 1.00 (0.96–1.05) | 10,522 | 2,104 | 4.29 (4.20–4.38) | 5,078 | 1,016 | 2.36 (2.29–2.43) | 875 | 175 | 0.40 (0.38–0.43) |
| TOTAL | 27,352 | 5,470 | 1.51 (1.49–1.53) | 64,229 | 12,846 | 3.78 (3.75–3.81) | 48,253 | 9,651 | 2.65 (2.63–2.68) | 9,271 | 1,854 | 0.51 (0.50–0.52) |
aAnnual average cases are calculated by dividing the five-year total by five.
bRates are per 100,000 and are age-adjusted to the 2000 US standard population.
cICD-O-3 histology code 9560/0 and ICD-O-3 topography code C72.4 and C72.5.
dICD-O-3 histology code 8272/0 and ICD-O-3 topography code C75.1.
eICD-O-3 histology codes 9530/0, 9531/0, 9532/0, 9533/0, 9534/0, and 9537/0.
fICD-O-3 histology codes 9530/1, 9531/1, 9532/1, 9533/1, 9534/1, 9537/1, 9538/1, and 9539/1.
-Counts and rates are not presented when fewer than 16 cases were reported for the specific category. The suppressed cases are included in the counts and rates for totals.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval